# Omega-3 Inflammation Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/omega-3-inflammation-meta-analysis-evidence-review
Category: evidence-review
Summary: Omega-3 Inflammation Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syst
Last reviewed: 2026-06-14
Reviewed by: Migaku Evidence Review
# Omega-3 Inflammation Meta-analysis: What the Evidence Says

## Quick Answer

Omega-3 Inflammation Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Regulation of inflammation by omega-3 and omega-6 fatty acids: a meta-analysis of randomized trials | systematic review | 1 | 2026-05-05 | 10.3389/fnut.2026.1799601 |
| From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression | narrative review | 3 | 2026-04-22 | 10.3390/nu18091318 |

## What The Sources Report

- Endo and Arita found that omega-3 fatty acids integrate into phospholipid bilayers, thereby influencing membrane fluidity, lipid microdomain formation, and transmembrane signaling, as well as modulating ion channels to prevent arrhythmias. [Huang Zicheng (2026); evidence level 1]
- However, whether increased omega-6 or LA intake exacerbates inflammation remains debated. [Huang Zicheng (2026); evidence level 1]
- A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations. [Hachmeriyan Antoniya (2026); evidence level 3]
- Clinically, mood disorders associated with IEMs often exhibit characteristic diagnostic patterns that may aid early recognition. [Hachmeriyan Antoniya (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For omega-3 inflammation meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Huang Zicheng (2026). Regulation of inflammation by omega-3 and omega-6 fatty acids: a meta-analysis of randomized trials. DOI: 10.3389/fnut.2026.1799601. PMCID: PMC13185561. PMID: 42163966. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13185561/
- Hachmeriyan Antoniya (2026). From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression. DOI: 10.3390/nu18091318. PMCID: PMC13165168. PMID: 42123920. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13165168/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.